Search
for
Sort by
Research 661–690 of 1000+
- Trichoscopic features of androgenetic alopecia according to the basic and specific (BASP) classification: A retrospective observational study
- Is androgenetic alopecia a marker of arrhythmia?: A case-control study
- Efficacy of Platelet-Rich Plasma in Males With Androgenetic Alopecia
- Low-level light therapy versus topical 5% minoxidil in the management of androgenetic alopecia in males: A randomised controlled trial
- Management of Androgenetic Alopecia
- The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study
- Quality of Life Assessment in Male Patients With Androgenetic Alopecia
- Genome-wide Scan and Fine-Mapping Linkage Study of Androgenetic Alopecia Reveals a Locus on Chromosome 3q26
- Guidelines based management of androgenetic alopecia
- Assessment of Safe Donor Zone of Scalp and Beard for Follicular Unit Extraction in Indian Men: A Study of 580 Cases.
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- Evaluation of Efficacy of Platelet rich Plasma on Androgenetic Alopecia: A Multimodal Assessment Using Trichoscopy, Histopathology, and CD34 Immunohistochemical Assay
- Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia
- Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia
- Anterolateral leg alopecia: Common but commonly ignored
- Efficacy of Platelet Rich Plasma and Concentrated Growth Factor in Treating Androgenetic Alopecia: A Split-Scalp Study
- Growth Factor Cocktail Including Fibroblast Growth Factor 9 (Cellcurin) in the Treatment of Androgenetic Alopecia in Men and Women: A Randomized Controlled Trial
- Morphological substantiation of clinical efficacy of platelet rich plasma in males with androgenic alopecia
- Are 2D:4D finger-length ratios an indicator of androgenetic alopecia in males?
- Association of Baldness with Coronary Artery Disease and Its Severity
- Efficacy and Safety of a Botanical Topical Serum on Male and Female Androgenetic Alopecia
- Androgenic alopecia in post-menopausal female: a clinical presentation
- Knowledge about androgenetic alopecia among women and men – a survey research
- Efficacy, Safety, and Tolerability of a Wearable Electrotrichogenic Device in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Sham-Controlled Trial
- Comparative Study of a Topical and Oral Combination Therapy Containing Oleanolic Acid, Apigenin, and Biotinyl Tripeptide-1 in Patients with Androgenetic Alopecia: A Prospective, Open-Label Trial
- A Study on the Effectiveness and Safety of Herbal Extract Combination Compared to 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A Randomized, Double-blind, Controlled Trial
- Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
- Long‐Term Efficacy and Safety of Low‐Level Laser Therapy for Androgenetic Alopecia: A 12‐Month Prospective Trial
- Therapeutic Potential of Adipose-Derived Stem Cells and Their Secretome in Reversible Alopecias: A Systematic Review